(CCEI) CIBC Canadian Equity Index - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA12565U1057

CCEI: Canadian,Equities,Shares,Stocks,Index

The CIBC Canadian Equity Index ETF (CCEI) is an exchange-traded fund that tracks the performance of the Canadian equity market, providing investors with broad diversification and exposure to the countrys top companies. As a passively managed fund, it aims to replicate the returns of its underlying index, which is rated by Morningstar Canada GR CAD.

With a focus on Canadian equities, CCEI offers a straightforward investment solution for those seeking to capitalize on the countrys economic growth. The funds underlying holdings are likely comprised of prominent Canadian companies across various sectors, such as finance, energy, and materials, which are typically representative of the Canadian economy.

Analyzing the funds recent price action, we observe a positive trend, with the last price of $27.62 exceeding its 20-day, 50-day, and 200-day simple moving averages (SMA20, SMA50, and SMA200) of $26.77, $26.68, and $26.24, respectively. This indicates a potential bullish momentum, as the price has broken through key resistance levels. The Average True Range (ATR) of 0.42, equivalent to 1.51% of the last price, suggests relatively moderate volatility.

Considering the funds assets under management (AUM) of $487.60M CAD, we can infer that CCEI has a reasonable size, which can contribute to liquidity and potentially lower trading costs. However, it is not among the largest ETFs in Canada, which may impact its trading volume and, consequently, its liquidity.

By combining the technical and fundamental data, we can forecast that CCEI may continue its upward trend, driven by the overall Canadian equity market performance. If the current momentum persists, the funds price may reach the upper end of its 52-week range, potentially testing the $27.87 level. Conversely, a decline in the Canadian market could lead to a pullback, with support likely to be found around the $26.68 (SMA50) or $26.24 (SMA200) levels. As such, a potential trading strategy could involve monitoring the funds price action and adjusting positions accordingly, with a stop-loss around $26.50 and a take-profit around $28.00.

Additional Sources for CCEI ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CCEI ETF Overview

Market Cap in USD 354m
Category Canadian Equity
IPO / Inception 2021-03-31

CCEI ETF Ratings

Growth Rating 71.4
Fundamental -
Dividend Rating 62.0
Rel. Strength 12.7
Analysts -
Fair Price Momentum 29.84 CAD
Fair Price DCF -

CCEI Dividends

Dividend Yield 12m 2.31%
Yield on Cost 5y 3.58%
Annual Growth 5y 25.84%
Payout Consistency 96.5%
Payout Ratio %

CCEI Growth Ratios

Growth Correlation 3m 86.5%
Growth Correlation 12m 83.3%
Growth Correlation 5y 84%
CAGR 5y 11.98%
CAGR/Max DD 5y 0.72
Sharpe Ratio 12m 1.63
Alpha 19.43
Beta 0.581
Volatility 11.76%
Current Volume 0.3k
Average Volume 20d 4.1k
What is the price of CCEI shares?
As of June 23, 2025, the stock is trading at CAD 28.95 with a total of 300 shares traded.
Over the past week, the price has changed by -0.28%, over one month by +2.55%, over three months by +5.49% and over the past year by +25.73%.
Is CIBC Canadian Equity Index a good stock to buy?
Yes. Based on ValueRay´s Analyses, CIBC Canadian Equity Index (TO:CCEI) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 71.35 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CCEI is around 29.84 CAD . This means that CCEI is currently overvalued and has a potential downside of 3.07%.
Is CCEI a buy, sell or hold?
CIBC Canadian Equity Index has no consensus analysts rating.
What are the forecasts for CCEI share price target?
According to our own proprietary Forecast Model, CCEI CIBC Canadian Equity Index will be worth about 33 in June 2026. The stock is currently trading at 28.95. This means that the stock has a potential upside of +13.89%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 33 13.9%